Wearable Health Solutions, Inc. (WHSI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 223.17 Thousand USD | -34.18% |
| 2022 | 339.06 Thousand USD | -62.65% |
| 2021 | 907.8 Thousand USD | 40.9% |
| 2020 | 644.3 Thousand USD | 120.33% |
| 2019 | 292.42 Thousand USD | 27.13% |
| 2018 | 230.01 Thousand USD | -44.67% |
| 2017 | 415.71 Thousand USD | -27.17% |
| 2016 | 570.83 Thousand USD | 107.84% |
| 2015 | 274.65 Thousand USD | -76.46% |
| 2014 | 1.16 Million USD | -7.35% |
| 2013 | 1.25 Million USD | -10.06% |
| 2012 | 1.4 Million USD | 1.59% |
| 2011 | 1.37 Million USD | -28.75% |
| 2010 | 1.93 Million USD | -18.46% |
| 2009 | 2.37 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 125.31 Thousand USD | -43.85% |
| 2024 Q2 | 89.58 Thousand USD | -28.52% |
| 2023 FY | 223.17 Thousand USD | -34.18% |
| 2023 Q1 | 426.15 Thousand USD | 25.69% |
| 2023 Q4 | 223.17 Thousand USD | 71.78% |
| 2023 Q3 | 129.91 Thousand USD | -37.78% |
| 2023 Q2 | 208.79 Thousand USD | -51.0% |
| 2022 FY | 339.06 Thousand USD | -62.65% |
| 2022 Q1 | 1.86 Million USD | 105.28% |
| 2022 Q2 | 1.68 Million USD | -9.6% |
| 2022 Q3 | 632.32 Thousand USD | -62.47% |
| 2022 Q4 | 339.06 Thousand USD | -46.38% |
| 2021 Q3 | 534.92 Thousand USD | 0.0% |
| 2021 FY | 907.8 Thousand USD | 40.9% |
| 2021 Q4 | 907.8 Thousand USD | 69.71% |
| 2021 Q1 | 734.46 Thousand USD | 13.99% |
| 2020 Q3 | 263.89 Thousand USD | 31.45% |
| 2020 FY | 644.3 Thousand USD | 120.33% |
| 2020 Q1 | 128.59 Thousand USD | -56.02% |
| 2020 Q2 | 200.75 Thousand USD | 56.11% |
| 2020 Q4 | 644.3 Thousand USD | 144.15% |
| 2019 Q3 | 295.1 Thousand USD | -0.9% |
| 2019 FY | 292.42 Thousand USD | 27.13% |
| 2019 Q2 | 297.78 Thousand USD | 0.61% |
| 2019 Q1 | 295.97 Thousand USD | 28.68% |
| 2019 Q4 | 292.42 Thousand USD | -0.91% |
| 2018 Q1 | 426.96 Thousand USD | 2.7% |
| 2018 FY | 230.01 Thousand USD | -44.67% |
| 2018 Q4 | 230.01 Thousand USD | -6.51% |
| 2018 Q3 | 246.02 Thousand USD | -24.13% |
| 2018 Q2 | 324.28 Thousand USD | -24.05% |
| 2017 Q4 | 415.71 Thousand USD | -13.52% |
| 2017 Q3 | 480.72 Thousand USD | 20.29% |
| 2017 Q2 | 399.63 Thousand USD | -6.75% |
| 2017 Q1 | 428.57 Thousand USD | -24.92% |
| 2017 FY | 415.71 Thousand USD | -27.17% |
| 2016 Q4 | 570.83 Thousand USD | 12.82% |
| 2016 Q2 | 217.61 Thousand USD | -22.57% |
| 2016 Q1 | 281.05 Thousand USD | 2.33% |
| 2016 Q3 | 505.97 Thousand USD | 132.51% |
| 2016 FY | 570.83 Thousand USD | 107.84% |
| 2015 Q3 | 1.22 Million USD | -3.87% |
| 2015 Q4 | 274.65 Thousand USD | -77.54% |
| 2015 Q1 | 1.17 Million USD | 0.44% |
| 2015 FY | 274.65 Thousand USD | -76.46% |
| 2015 Q2 | 1.27 Million USD | 8.51% |
| 2014 Q3 | 1.19 Million USD | -1.63% |
| 2014 FY | 1.16 Million USD | -7.35% |
| 2014 Q4 | 1.16 Million USD | -1.98% |
| 2014 Q2 | 1.21 Million USD | -3.91% |
| 2014 Q1 | 1.25 Million USD | -0.0% |
| 2013 Q1 | 1.01 Million USD | -27.77% |
| 2013 Q2 | 1.28 Million USD | 27.51% |
| 2013 Q3 | 1.42 Million USD | 10.87% |
| 2013 Q4 | 1.25 Million USD | -11.92% |
| 2013 FY | 1.25 Million USD | -10.06% |
| 2012 Q2 | 1.32 Million USD | -1.78% |
| 2012 Q3 | 1.46 Million USD | 10.64% |
| 2012 Q4 | 1.4 Million USD | -4.72% |
| 2012 FY | 1.4 Million USD | 1.59% |
| 2012 Q1 | 1.35 Million USD | -1.89% |
| 2011 Q1 | 1.69 Million USD | -12.5% |
| 2011 Q2 | 1.52 Million USD | -9.68% |
| 2011 Q4 | 1.37 Million USD | -1.66% |
| 2011 FY | 1.37 Million USD | -28.75% |
| 2011 Q3 | 1.4 Million USD | -8.31% |
| 2010 Q2 | 2.37 Million USD | 12.78% |
| 2010 FY | 1.93 Million USD | -18.46% |
| 2010 Q4 | 1.93 Million USD | -11.24% |
| 2010 Q3 | 2.17 Million USD | -8.04% |
| 2010 Q1 | 2.1 Million USD | -11.42% |
| 2009 Q3 | 2.56 Million USD | 3.02% |
| 2009 Q4 | 2.37 Million USD | -7.53% |
| 2009 Q1 | 487.92 Thousand USD | 0.0% |
| 2009 Q2 | 2.49 Million USD | 410.43% |
| 2009 FY | 2.37 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | 87.858% |
| Ansell Limited | 3.23 Billion USD | 99.993% |
| Ansell Limited | 3.24 Billion USD | 99.993% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | 99.954% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | 25.699% |
| Psykey, Inc. | 1.72 Million USD | 87.08% |
| ConvaTec Group Plc | 3.7 Billion USD | 99.994% |
| ConvaTec Group Plc | 3.71 Billion USD | 99.994% |
| Encision Inc. | 3.81 Million USD | 94.144% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | 65.765% |
| LifePoint, Inc. | 8.8 Million USD | 97.467% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 98.601% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | 75.064% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | 95.934% |
| Reflect Scientific, Inc. | 2.66 Million USD | 91.638% |
| SmileDirectClub, Inc. | 597.06 Million USD | 99.963% |
| Sector 10, Inc. | 1000.00 USD | -22217.3% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 99.995% |
| SheerVision, Inc. | 837.56 Thousand USD | 73.355% |
| United Health Products, Inc. | 284.64 Thousand USD | 21.595% |
| Vasamed, Inc. | 1.6 Million USD | 86.054% |
| Yubo International Biotech Limited | 2.34 Million USD | 90.497% |